← Back to All Filings

Exelixis Director Files Intent to Sell $4.4M in Stock (EXEL)

Low SignificanceNovember 12, 2025 at 6:04:16 PM EST

EXELIXIS, INC.

$EXEL144CIK: 0000939767

Subscribe to track EXEL

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Exelixis Director Files Intent to Sell $4.4M in Stock (EXEL)

Company: EXELIXIS, INC. (EXEL) Form: 144 | Filed: 2025-11-12 Significance: Low

Insider: Stelios Papadopoulos Title: Director | Relationship: Director

Transaction: • Type: Proposed Sale • Shares: 100,000 • Value: $4,355,204

Key Insight: A director has filed a notice of intent to sell 100,000 shares. The transaction represents a very small fraction of the company's market cap (0.039%) and shares outstanding (0.037%).

Market Context: This is a routine filing for a proposed sale and is considered low significance due to its small size relative to the company's $11.1B market capitalization.

Comprehensive Analysis

SEC Filing Analysis: EXELIXIS, INC. (EXEL)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director filed a notice of intent to sell approximately $4.4 million worth of EXEL stock, a transaction of low materiality relative to the company's size.
  • Market Impact: Minimal impact is expected due to the small size of the proposed sale.

Company Information

FieldValue
CompanyEXELIXIS, INC.
Ticker SymbolEXEL
CIK0000939767
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameStelios Papadopoulos
CIK0001202098
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type144
Transaction Date2025-11-12 (Approximate Sale Date)
Transaction CodeS (Proposed Sale)
Security TypeCommon stock
Shares Involved100,000
Price Per Share$43.55 (approximate)
Total Value$4,355,204.43
Shares Owned AfterNot specified
Ownership TypeNot specified

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$4,355,204.43
% of Market Cap0.039%
Shares Transacted100,000
% of Shares Outstanding0.037%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The proposed $4.4 million sale is a minor event for a company with an $11.1 billion market capitalization.
  • Transaction Significance: The sale represents just 0.039% of the market cap and 0.037% of shares outstanding, falling well below the thresholds for moderate or high significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: A small, planned sale by a single director, filed via Form 144, is a routine disclosure and is unlikely to influence market sentiment or stock price.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The number of shares is small compared to typical daily trading volume.
  • Sentiment Indicator: Neutral. This filing does not provide a strong bullish or bearish signal.

Additional Context

Transaction Notes

  • This Form 144 filing serves as a notice of a proposed sale. The transaction has not yet occurred but may take place within the next 90 days. It allows the insider to sell restricted securities in the public market.
Topics:#SECFiling#InsiderTrading#EXEL#Exelixis#Form144#InsiderSell#StockMarket#Investing#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.